You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯公告精選(港股)︱心瑋醫療-B(06609.HK)盈喜:預計中期淨利潤不少於4000萬元

【今日焦點】

心瑋醫療-B(06609.HK)盈喜:預計中期淨利潤不少於4000萬元

心瑋醫療-B(06609.HK)發佈公告,截至2025年6月30日止六個月(“報告期間”),集團預期錄得股東應佔淨利潤不少於人民幣4000萬元,較截至2024年6月30日止六個月(“相應期間”)錄得的股東應佔淨虧損約人民幣510萬元大幅轉虧爲盈。預期錄得利潤及業績改善主要由於集團的業務增長,導致與相應期間相比的收益增加及集團整體開支比率下降。

【重大事項】

瑞和數智(03680.HK)與一家獨立第三方機構達成虛擬加密資產交易平臺聯合開發的合作框架協議

中基長壽科學(00767.HK)擬攜手好柿多(深圳)共同合作長壽檢測、長壽管理等業務

英諾賽科(02577.HK)與聯合電子成立氮化鎵技術聯合實驗室

利記(00637.HK)附屬簽署收地協議 寧波鎮浦路三期項目補償金逾1400萬港元

濱海投資(02886.HK)與天津特檢院簽署戰略合作框架協議

天利控股集團(00117.HK):建議增加法定股本

誼礫控股(00076.HK)合作開發礦產品交易生態 支持"76碼"代金券及穩定幣支付

【財報業績】

寶勝國際(03813.HK)預計中期純利約1.876億元 同比減少44.1%

百奧家庭互動(02100.HK)盈喜:預期中期利潤增加約134.9%至141.6%

創維集團(00751.HK)盈警:預計中期稅後溢利同比將錄得約50%的下降幅度

【運營數據】

中國中車(01766.HK)近期簽訂約329.2億元重大合同

中國電力(02380.HK)6月合併總售電量1129.9萬兆瓦時 同比減少5.04%

【醫藥創新】

上海醫藥(02607.HK):B019新適應症獲得臨牀試驗批準通知書

【收購出售】

電訊數碼控股(06033.HK)擬4000萬港元收購電訊數碼證券全部股權

【股權激勵】

奇點國峯(01280.HK)授出2340萬股獎勵股份

百望股份(06657.HK)授出475萬股受限制股份

【增發供股】

創業集團控股(02221.HK)擬溢價約44.93%配發2.2億股 淨籌2202萬港元

智雲國際(08521.HK)擬折讓約16.48%配發合共6300萬股 淨籌約4762萬港元

珠江鋼管(01938.HK)建議股份溢價削減

【回購註銷】

渣打集團(02888.HK)7月28日耗資965.5萬英鎊回購71.9萬股

首程控股(00697.HK)7月29日耗資3230萬港元回購1765萬股

保誠(02378.HK)7月28日耗資302.3萬英鎊回購32.2萬股

貝殼-W(02423.HK)7月28日耗資300萬美元回購46.1萬股

藥明康德(02359.HK):調整A股回購價格上限

美的集團(00300.HK)7月29日耗資1992.3萬港元回購25.3萬股

濰柴動力(02338.HK)7月29日耗資1174.17萬元回購76.99萬股A股

VITASOY INT'L(00345.HK)7月29日耗資1112.61萬港元回購120.2萬股

中國外運(00598.HK)註銷2202萬股H股

匯豐控股(00005.HK)7月28日註銷311.13萬股股份

力鴻檢驗(01586.HK)7月29日註銷438.4萬股

WING ON CO(00289.HK)7月29日註銷9.4萬股購回股份

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account